Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384525577> ?p ?o ?g. }
- W4384525577 endingPage "1240" @default.
- W4384525577 startingPage "1240" @default.
- W4384525577 abstract "Antibody Dependent Enhancement (ADE) of an infection has been of interest in the investigation of many viruses. It is associated with the severity of the infection. ADE is mediated by non-neutralizing antibodies, antibodies at sub-neutralizing concentrations, or cross-reactive non-neutralizing antibodies. Treatments like plasma therapy, B cell immunizations, and antibody therapies may trigger ADE. It is seen as an impediment to vaccine development as well. In viruses including the Dengue virus (DENV), severe acute respiratory syndrome (SARS) virus, Middle East respiratory syndrome (MERS) virus, human immunodeficiency virus (HIV), Ebola virus, Zika virus, and influenza virus, the likely mechanisms of ADE are postulated and described. ADE improves the likelihood of productively infecting cells that are expressing the complement receptor or the Fc receptor (FcR) rather than the viral receptors. ADE occurs when the FcR, particularly the Fc gamma receptor, and/or complement system, particularly Complement 1q (C1q), allow the entry of the virus-antibody complex into the cell. Moreover, ADE alters the innate immune pathways to escape from lysis, promoting viral replication inside the cell that produces viral particles. This review discusses the involvement of FcR and the downstream immunomodulatory pathways in ADE, the complement system, and innate antiviral signaling pathways modification in ADE and its impact on facilitating viral replication. Additionally, we have outlined the modes of ADE in the cases of different viruses reported until now." @default.
- W4384525577 created "2023-07-18" @default.
- W4384525577 creator A5001370023 @default.
- W4384525577 creator A5043206907 @default.
- W4384525577 creator A5079587734 @default.
- W4384525577 date "2023-07-14" @default.
- W4384525577 modified "2023-09-30" @default.
- W4384525577 title "A Review: Understanding Molecular Mechanisms of Antibody-Dependent Enhancement in Viral Infections" @default.
- W4384525577 cites W1579632014 @default.
- W4384525577 cites W1991656907 @default.
- W4384525577 cites W1991982546 @default.
- W4384525577 cites W2003583702 @default.
- W4384525577 cites W2009769910 @default.
- W4384525577 cites W2011644307 @default.
- W4384525577 cites W2029415712 @default.
- W4384525577 cites W2029621165 @default.
- W4384525577 cites W2033702349 @default.
- W4384525577 cites W2052669763 @default.
- W4384525577 cites W2058757536 @default.
- W4384525577 cites W2061134744 @default.
- W4384525577 cites W2101288286 @default.
- W4384525577 cites W2102144534 @default.
- W4384525577 cites W2109082162 @default.
- W4384525577 cites W2121585949 @default.
- W4384525577 cites W2127896903 @default.
- W4384525577 cites W2132994022 @default.
- W4384525577 cites W2134057839 @default.
- W4384525577 cites W2134266729 @default.
- W4384525577 cites W2134966592 @default.
- W4384525577 cites W2137257347 @default.
- W4384525577 cites W2159276552 @default.
- W4384525577 cites W2160766576 @default.
- W4384525577 cites W2166183736 @default.
- W4384525577 cites W2395756853 @default.
- W4384525577 cites W2461721619 @default.
- W4384525577 cites W2468976441 @default.
- W4384525577 cites W2565823342 @default.
- W4384525577 cites W2618810381 @default.
- W4384525577 cites W2752357923 @default.
- W4384525577 cites W2793126034 @default.
- W4384525577 cites W2801910529 @default.
- W4384525577 cites W2886030181 @default.
- W4384525577 cites W2902543952 @default.
- W4384525577 cites W2936164317 @default.
- W4384525577 cites W2995449088 @default.
- W4384525577 cites W2998874290 @default.
- W4384525577 cites W3000678087 @default.
- W4384525577 cites W3009912996 @default.
- W4384525577 cites W3025969587 @default.
- W4384525577 cites W3033232156 @default.
- W4384525577 cites W3039945792 @default.
- W4384525577 cites W3041959031 @default.
- W4384525577 cites W3044722686 @default.
- W4384525577 cites W3048558989 @default.
- W4384525577 cites W3080236695 @default.
- W4384525577 cites W3083763518 @default.
- W4384525577 cites W3083773456 @default.
- W4384525577 cites W3086741758 @default.
- W4384525577 cites W3089648802 @default.
- W4384525577 cites W3093015991 @default.
- W4384525577 cites W3093768302 @default.
- W4384525577 cites W3110875071 @default.
- W4384525577 cites W3157625523 @default.
- W4384525577 cites W3160153707 @default.
- W4384525577 cites W3173611083 @default.
- W4384525577 cites W3176969175 @default.
- W4384525577 cites W3203935799 @default.
- W4384525577 cites W4220886005 @default.
- W4384525577 cites W4221135175 @default.
- W4384525577 cites W4225685433 @default.
- W4384525577 cites W4281912930 @default.
- W4384525577 cites W4282838395 @default.
- W4384525577 cites W4296160968 @default.
- W4384525577 cites W4307899089 @default.
- W4384525577 cites W4308887989 @default.
- W4384525577 cites W4310482455 @default.
- W4384525577 cites W4311585162 @default.
- W4384525577 cites W4318035349 @default.
- W4384525577 cites W4321616928 @default.
- W4384525577 cites W4323566584 @default.
- W4384525577 cites W4362467683 @default.
- W4384525577 cites W4376280126 @default.
- W4384525577 cites W4377696089 @default.
- W4384525577 cites W4380143017 @default.
- W4384525577 doi "https://doi.org/10.3390/vaccines11071240" @default.
- W4384525577 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37515055" @default.
- W4384525577 hasPublicationYear "2023" @default.
- W4384525577 type Work @default.
- W4384525577 citedByCount "0" @default.
- W4384525577 crossrefType "journal-article" @default.
- W4384525577 hasAuthorship W4384525577A5001370023 @default.
- W4384525577 hasAuthorship W4384525577A5043206907 @default.
- W4384525577 hasAuthorship W4384525577A5079587734 @default.
- W4384525577 hasBestOaLocation W43845255771 @default.
- W4384525577 hasConcept C111684460 @default.
- W4384525577 hasConcept C136449434 @default.
- W4384525577 hasConcept C140704245 @default.
- W4384525577 hasConcept C159047783 @default.